Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 349-358 , June 2010

Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection

  • Sara Raimondi (Researcher)

      Affiliations

    • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    • ,
  • Albert B. Lowenfels (Professor of Surgery)

      Affiliations

    • New York Medical College Valhalla, NY 10595, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 914 594 4260; fax: +1 914 594 3481.
    • ,
  • Antonio M. Morselli-Labate (Research Fellow)

      Affiliations

    • Department of Digestive Diseases and Internal Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy
    • ,
  • Patrick Maisonneuve (Head of Department)

      Affiliations

    • Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy
    • ,
  • Raffaele Pezzilli (Head of Pancreas Unit)

      Affiliations

    • Department of Digestive Diseases and Internal Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy

References 

  1. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow?. Lancet. 2001;357:539–545
  2. Thun MJ, Henley SJ, Gansler T. Inflammation and cancer: an epidemiological perspective. Novartis Found Symp. 2004;256:6–21
  3. Logsdon CD, Ji B. Ras activity in acinar cells links chronic pancreatitis and pancreatic cancer. Clin Gastroenterol Hepatol. 2009;7:S40–S43
  4. Ji B, Tsou L, Wang H, et al. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009;137:1072–1082
  5. Hingorani SR, Petricoin EF, Maitra A, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell. 2003;4:437–450
  6. Carriere C, Young AL, Gunn JR, et al. Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. Biochem Biophys Res Commun. 2009;382:561–565
  7. Parkin DM, Whelan SL, Ferlay J, Maitra A, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication; 2002;n. 155
  8. Wynder EL, Mabuchi K, Maruchi N, et al. Epidemiology of cancer of the pancreas. J Natl Cancer Inst. 1973;50:645–667
  9. Lin RS, Kessler II. A multifactorial model for pancreatic cancer in man. Epidemiologic evidence. JAMA. 1981;245:147–152
  10. Gold EB, Gordis L, Diener MD, et al. Diet and other risk factors for cancer of the pancreas. Cancer. 1985;55:460–467
  11. Mack TM, Yu MC, Hanisch R, et al. Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst. 1986;76:49–60
  12. Farrow DC, Davis S. Risk of pancreatic cancer in relation to medical history and the use of tobacco, alcohol and coffee. Int J Cancer. 1990;45:816–820
  13. Jain M, Howe GR, St Louis P, et al. Coffee and alcohol as determinants of risk of pancreas cancer: a case-control study from Toronto. Int J Cancer. 1991;47:384–389
  14. Bueno de Mesquita HB, Maisonneuve P, Moerman CJ, et al. Aspects of medical history and exocrine carcinoma of the pancreas: a population-based case-control study in The Netherlands. Int J Cancer. 1992;52:17–23
  15. Kalapothaki V, Tzonou A, Hsieh CC, et al. Tobacco, ethanol, coffee, pancreatitis, diabetes mellitus, and cholelithiasis as risk factors for pancreatic carcinoma. Cancer Causes Control. 1993;4:375–382
  16. Fernandez E, La Vecchia C, Porta M, et al. Pancreatitis and the risk of pancreatic cancer. Pancreas. 1995;11:185–189
  17. Bansal P, Sonnenberg A. Pancreatitis is a risk factor for pancreatic cancer. Gastroenterology. 1995;109:247–251
  18. Burch GE, Ansari A. Chronic alcoholism and carcinoma of the pancreas. A correlative hypothesis. Arch Intern Med. 1968;122:273–275
  19. Bracci PM, Wang F, Hassan MM, et al. Pancreatitis and pancreatic cancer in two large pooled case-control studies. Cancer Causes Control. 2009;20:1723–1731
  20. Rocca G, Gaia E, Iuliano R, et al. Increased incidence of cancer in chronic pancreatitis. J Clin Gastroenterol. 1987;9:175–179
  21. Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International pancreatitis study group. N Engl J Med. 1993;328:1433–1437
  22. Chari ST, Mohan V, Pitchumoni CS, et al. Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas. 1994;9:62–66
  23. Karlson BM, Ekbom A, Josefsson S, et al. The risk of pancreatic cancer following pancreatitis: an association due to confounding?. Gastroenterology. 1997;113:587–592
  24. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut. 2002;51:849–852
  25. Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252–261
  26. Rebours V, Boutron-Ruault MC, Schnee M, et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol. 2008;103:111–119
  27. Lowenfels AB, Maisonneuve P, Whitcomb DC. Risk factors for cancer in hereditary pancreatitis. International hereditary pancreatitis study group. Med Clin North Am. 2000;84:565–573
  28. Pedrazzoli S, Pasquali C, Guzzinati S, et al. Survival rates and cause of death in 174 patients with chronic pancreatitis. J Gastrointest Surg. 2008;12:1930–1937
  29. Goldacre MJ, Wotton CJ, Yeates D, et al. Liver cirrhosis, other liver diseases, pancreatitis and subsequent cancer: record linkage study. Eur J Gastroenterol Hepatol. 2008;20:384–392
  30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188
  31. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  32. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  33. Maisonneuve P, Marshall BC, Lowenfels AB. Risk of pancreatic cancer in patients with cystic fibrosis. Gut. 2007;56:1327–1328
  34. U.S. Preventive Services Task Force . Screening for pancreatic cancer. Rockville, MD: Agency for Healthcare Research and Quality; 2004;http://www.ahrq.gov/clinic/uspstf/uspspanc.htm2010
  35. Steinberg WM, Barkin JS, et al. Bradley E.L Should patients with a strong family history of pancreatic cancer be screened on a periodic basis for cancer of the pancreas?. Pancreas. 2009;38:e137–e150
  36. Poley JW, Kluijt I, Gouma DJ, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol. 2009;104:2175–2181
  37. Canto MI, Goggins M, Yeo CJ, et al. Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol. 2004;2:606–621
  38. Langer P, Kann PH, Fendrich V, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut. 2009;58:1410–1418
  39. Ulrich CD. Pancreatic cancer in hereditary pancreatitis: consensus guidelines for prevention, screening and treatment. Pancreatology. 2001;1:416–422
  40. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al. Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology. 2005;129:1454–1463
  41. Bournet B, Souque A, Senesse P, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy coupled with KRAS mutation assay to distinguish pancreatic cancer from pseudotumoral chronic pancreatitis. Endoscopy. 2009;41:552–557
  42. Maluf-Filho F, Kumar A, Gerhardt R, et al. Kras mutation analysis of fine needle aspirate under EUS guidance facilitates risk stratification of patients with pancreatic mass. J Clin Gastroenterol. 2007;41:906–910
  43. Shi C, Fukushima N, Abe T, et al. Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection. Cancer Biol Ther. 2008;7:353–360
  44. Talar-Wojnarowska R, Gasiorowska A, Smolarz B, et al. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis. J Physiol Pharmacol. 2004;55(Suppl. 2):129–138
  45. Furuya N, Kawa S, Akamatsu T, et al. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice. Gastroenterology. 1997;113:593–598
  46. In:  Horner MJ,  Ries LAG,  Krapcho M, et al. editor. SEER cancer statistics review, 1975–2006. Bethesda, MD: National Cancer Institute; 2008;http://seer.cancer.gov/csr/1975_2006/SEER data submission, posted to the SEER web site, 2009
  47. Rohrmann S, Linseisen J, Vrieling A, et al. Ethanol intake and the risk of pancreatic cancer in the European prospective Investigation into cancer and Nutrition (EPIC). Cancer Causes Control. 2009;20:785–794
  48. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology. 2008;134:95–101
  49. Lesniak RJ, Hohenwalter MD, Taylor AJ. Spectrum of causes of pancreatic calcifications. AJR Am J Roentgenol. 2002;178:79–86
  50. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699–708
  51. Lowenfels AB. Epidemiology of chronic pancreatitis. In:  Forsmark CE editors. Pancreatitis and its complications. New Jersey: Humana Press; 2005;[Chapter 9]

☆ Supported by grants from Solvay Pharmaceuticals, and the C.D. Smithers Foundation.

PII: S1521-6918(10)00021-1

doi: 10.1016/j.bpg.2010.02.007

Best Practice & Research Clinical Gastroenterology
Volume 24, Issue 3 , Pages 349-358 , June 2010

Article Tools

* Image Usage & Resolution